This review first addresses several general aspects of the immunotherapy of
multiple sclerosis. Next, two approved immunomodulatory treatments, interf
eron-beta and copolymer-1 (glatiramer acetate), are reviewed in more detail
. Finally, other immunosuppressive therapies and experimental strategies ar
e briefly discussed.